Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder CandidateBenzinga • 09/29/21
CRISPR Therapeutics to Participate in the Chardan's 5th Annual Genetic Medicines ConferenceGlobeNewsWire • 09/28/21
Why CRISPR Therapeutics AG (CRSP) is a Top Stock for the Long-TermZacks Investment Research • 09/17/21
CRISPR Therapeutics AG (CRSP) Stock Moves -0.59%: What You Should KnowZacks Investment Research • 09/11/21
Crispr Therapeutics: Lucrative Partnerships And Promising Data Increase Its AppealSeeking Alpha • 08/28/21
Earnings Growth & Price Strength Make CRISPR Therapeutics AG (CRSP) a Stock to WatchZacks Investment Research • 08/24/21